Evidence map›Paper›PMID 42696148›Full record

ArticleActa neuropathologica2026

Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.

Julia Konings, Fleur Mingneau, Serhii Chornyi, Cathrin E Hansen, Rianne T M van der Burgt, Tessa G van Elk, Laura Bolkaerts, Bo Batens, Gábor Tóth, Ingela Lanekoff and 13 more

Abstract readPublished Erratum
In one paragraph

Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Julia KoningsDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Fleur MingneauDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Serhii ChornyiDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Cathrin E HansenDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Rianne T M van der BurgtDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Tessa G van ElkDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Laura BolkaertsDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Bo BatensDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Gábor TóthDepartment of Chemistry for Life Sciences, Uppsala University, Uppsala, Sweden.
Ingela LanekoffDepartment of Chemistry for Life Sciences, Uppsala University, Uppsala, Sweden.
Frédéric M VazLaboratory Genetic Metabolic Diseases, Amsterdam UMC, Amsterdam, The Netherlands.
Alessio CardilliDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Marie SelsDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Susanne M A van der PolDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Helga E de VriesDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Martin GieraCenter for Proteomics and Metabolomics, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
Oliver WerzDepartment of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, Jena, Germany.
Sofie KesselsDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Sanne G S VerberkDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Jeroen F J BogieDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Merel RijnsburgerDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Jerome J A HendriksDepartment of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Gijs KooijDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. g.kooij@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42696148
PMCPMC13545101

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.